<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Anxiety and depression, highly comorbid psychiatric conditions, are chronic and recurring disorders associated with biochemical, cognitive, behavioral, and psychological changes that can cause a significant socioeconomic burden.
 <sup class="sup">
  <xref rid="ref1" ref-type="bibr" class="xref">1</xref>,
  <xref rid="ref2" ref-type="bibr" class="xref">2</xref>
 </sup> The prevalence rate of depression is about 15% during the lifecycle and is considered as one of the main reasons of disability. It is ranked fourth among the top ten main reasons of disease load in the world. It is also reported that about 500 million people suffer from anxiety disorder around the world.
 <sup class="sup">
  <xref rid="ref1" ref-type="bibr" class="xref">1</xref>
 </sup> The increasing number of patients with these disorders encourages research on developing effective drugs to prevent or treats such diseases.
 <sup class="sup">
  <xref rid="ref3" ref-type="bibr" class="xref">3</xref>
 </sup>
</p>
